Ryan Conrad

Articles by Ryan Conrad

Who Are the Winners and Losers With FDA's Priority Review Voucher Program?

November 20th 2025

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, he provides a broad overview of the possible positive and negative impacts of FDA’s Priority Review Voucher Program.

Latest Updated Articles

Trending on PharmExec

Moderna Investing $140 Million in Massachusetts Manufacturing Facility

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

Pharmaceutical Executive Daily: FDA's Approval of Epkinly

GSK Announces Research Collaborations with LTZ and Fleming Initiative

Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer